Hydrogen bonding penalty upon ligand binding

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Zhao, Hongtao ^a   Huang, Danzhi ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR B4 INHIBITOR; LIGAND; MOLECULAR SCAFFOLD; PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; WATER;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG STRUCTURE; ENERGY; HIGH THROUGHPUT SCREENING; HYDROGEN BOND; LIGAND BINDING; MOLECULAR DOCKING; CHEMISTRY; PROTEIN BINDING; THERMODYNAMICS;

HYDROGEN BONDING; LIGANDS; PROTEIN BINDING; PROTEINS; THERMODYNAMICS;

EID: 79959222106     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019923     Document Type: Article

References (42)

1. Wilkinson AJ, Fersht AR, Blow DM, Winter G, (1983) Site-directed mutagenesis as a probe of enzyme structure and catalysis: tyrosyl-tRNA synthetase cysteine-35 to glycine-35 mutation. Biochemistry 22: 3581-3586.
2. Winter G, Fersht AR, Wilkinson AJ, Zoller M, Smith M, (1982) Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding. Nature 299: 756-758.
3. Wilkinson AJ, Fersht AR, Blow DM, Carter P, Winter G, (1984) A large increase in enzyme-substrate affinity by protein engineering. Nature 307: 187-188.
4. Bajorath J, (2002) Integration of virtual and high-throughput screening. Nat Rev Drug Discov 1: 882-894.
5. Langer T, Hoffmann RD, (2001) Virtual screening: an effective tool for lead structure discovery? Curr Pharm Des 7: 509-527.
6. Honig B, Nicholls A, (1995) Classical electrostatics in biology and chemistry. Science 268: 1144-1149.
7. Feig M, Onufriev A, Lee MS, Im W, Case DA, et al. (2004) Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures. J Comput Chem 25: 265-284.
8. Schneider G, (2010) Virtual screening: an endless staircase? Nat Rev Drug Discov 9: 273-276.
9. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, et al. (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49: 6177-6196.
10. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, et al. (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47: 1739-1749.
11. Wang R, Lu Y, Wang S, (2003) Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem 46: 2287-2303.
12. Thilagavathi R, Mancera RL, (2010) Ligand-protein cross-docking with water molecules. J Chem Inf Model 50: 415-421.
13. Kolb P, Huang D, Dey F, Caflisch A, (2008) Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model. J Med Chem 51: 1179-1188.
14. Hunter T, (1998) The role of tyrosine phosphorylation in cell growth and disease. Harvey Lect 94: 81-119.
15. Pennisi A, Ling W, Li X, Khan S, Shaughnessy JD Jr, et al. (2009) The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth. Blood 114: 1803-1812.
16. Zhou T, Caflisch A, (2010) High-throughput virtual screening using quantum mechanical probes: discovery of selective kinase inhibitors. ChemMedChem 5: 1007-1014.
17. Miyazaki Y, Nakano M, Sato H, Truesdale AT, Stuart JD, et al. (2007) Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases. Bioorg Med Chem Lett 17: 250-254.
18. Bardelle C, Cross D, Davenport S, Kettle JG, Ko EJ, et al. (2008) Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines. Bioorg Med Chem Lett 18: 2776-2780.
19. Lafleur K, Huang D, Zhou T, Caflisch A, Nevado C, (2009) Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4). J Med Chem 52: 6433-6446.
20. Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, et al. (2008) A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26: 127-132.
21. Fersht AR, Shi JP, Knill-Jones J, Lowe DM, Wilkinson AJ, et al. (1985) Hydrogen bonding and biological specificity analysed by protein engineering. Nature 314: 235-238.
22. Hine J, (1972) Structural Effects on Rates and Equilibria. 15. Hydrogen-Bonded Intermediates and Stepwise Mechanisms for Proton-Exchange Reactions between Oxygen-Atoms in Hydroxylic Solvents. J Am Chem Soc 94: 5766-&.
23. Steiner T, Saenger W, (1993) Role of C-H. O Hydrogen-Bonds in the Coordination of Water-Molecules- Analysis of Neutron-Diffraction Data. J Am Chem Soc 115: 4540-4547.
24. Cordero B, Gomez V, Platero-Prats AE, Reves M, Echeverria J, et al. (2008) Covalent radii revisited. Dalton Trans pp. 2832-2838.
25. Bondi A, (1964) Van Der Waals Volumes+Radii. Journal of Physical Chemistry 68: 441-&.
26. Bohm HJ, (1994) The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J Comput Aided Mol Des 8: 243-256.
27. Morozov AV, Kortemme T, Tsemekhman K, Baker D, (2004) Close agreement between the orientation dependence of hydrogen bonds observed in protein structures and quantum mechanical calculations. Proc Natl Acad Sci U S A 101: 6946-6951.
28. Momany FA, Rone R, (1992) Validation of the General-Purpose Quanta(R)3.2/Charmm(R) Force-Field. J Comput Chem 13: 888-900.
29. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, et al. (1983) Charmm- a Program for Macromolecular Energy, Minimization, and Dynamics Calculations. J Comput Chem 4: 187-217.
30. Warwicker J, Watson HC, (1982) Calculation of the electric potential in the active site cleft due to alpha-helix dipoles. J Mol Biol 157: 671-679.
31. Im W, Beglov D, Roux B, (1998) Continuum Solvation Model: computation of electrostatic forces from numerical solutions to the Poisson-Boltzmann equation. Computer Physics Communications 111: 59-75.
32. Gibson AE, Arris CE, Bentley J, Boyle FT, Curtin NJ, et al. (2002) Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives. J Med Chem 45: 3381-3393.
33. Stelmach JE, Liu L, Patel SB, Pivnichny JV, Scapin G, et al. (2003) Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase. Bioorg Med Chem Lett 13: 277-280.
34. Berger DM, Torres N, Dutia M, Powell D, Ciszewski G, et al. (2009) Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors. Bioorg Med Chem Lett 19: 6519-6523.
35. Koch P, Jahns H, Schattel V, Goettert M, Laufer S, (2010) Pyridinylquinoxalines and pyridinylpyridopyrazines as lead compounds for novel p38 alpha mitogen-activated protein kinase inhibitors. J Med Chem 53: 1128-1137.
36. Goodsell DS, Olson AJ, (1990) Automated docking of substrates to proteins by simulated annealing. Proteins 8: 195-202.
37. No KT, Grant JA, Scheraga HA, (1990) Determination of Net Atomic Charges Using a Modified Partial Equalization of Orbital Electronegativity Method. 1. Application to Neutral Molecules as Models for Polypeptides. Journal of Physical Chemistry 94: 4732-4739.
38. No KT, Grant JA, Jhon MS, Scheraga HA, (1990) Determination of Net Atomic Charges Using a Modified Partial Equalization of Orbital Electronegativity Method. 2. Application to Ionic and Aromatic-Molecules as Models for Polypeptides. Journal of Physical Chemistry 94: 4740-4746.
39. Irwin JJ, Shoichet BK, (2005) ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model 45: 177-182.
40. Hawkins PC, Warren GL, Skillman AG, Nicholls A, (2008) How to do an evaluation: pitfalls and traps. J Comput Aided Mol Des 22: 179-190.
41. Yang CY, Sun H, Chen J, Nikolovska-Coleska Z, Wang S, (2009) Importance of ligand reorganization free energy in protein-ligand binding-affinity prediction. J Am Chem Soc 131: 13709-13721.
42. Hopkins AL, Groom CR, Alex A, (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9: 430-431.